Contemporary meta-analysis of short-term probiotic consumption on gastrointestinal transit

World Journal of Gastroenterology

Volumn 22, Issue 21, 2016, Pages 5122-5131

  Miller, Larry E ^a   Zimmermann, Angela K ^a   Ouwehand, Arthur C ^b  

^a Miller Scientific Consulting   (United States)

^b DUPONT COMPANY   (United States)

Author keywords

Constipation; Gastrointestinal; Intestinal transit time; Meta analysis; Probiotics

Indexed keywords

PROBIOTIC AGENT;

ARTICLE; BACTERIAL STRAIN; CONSTIPATION; DIGESTIVE TRACT PARAMETERS; GASTROINTESTINAL TRANSIT; HUMAN; INTESTINAL TRANSIT TIME; META ANALYSIS; PREDICTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SUPPLEMENTATION; SYSTEMATIC REVIEW; TREATMENT DURATION; GASTROINTESTINAL TRACT; INTESTINE FLORA; MICROBIOLOGY; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

CONSTIPATION; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; GASTROINTESTINAL TRANSIT; HUMANS; PROBIOTICS; TREATMENT OUTCOME;

EID: 84978915588     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i21.5122     Document Type: Article

References (34)

1. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993; 38: 1569-1580 [PMID: 8359066]
2. Camilleri M. Review article: biomarkers and personalised therapy in functional lower gastrointestinal disorders. Aliment Pharmacol Ther 2015; 42: 818-828 [PMID: 26264216 DOI: 10.1111/apt.13351]
3. European Food Safety Authority. Guidance on the scientific requirements for health claims related to gut and immune function. EFSA J 2011; 9: 1984
4. Tack J, Müller-Lissner S. Treatment of chronic constipation: current pharmacologic approaches and future directions. Clin Gastroenterol Hepatol 2009; 7: 502-508; quiz 496 [PMID: 19138759 DOI: 10.1016/j.cgh.2008.12.006]
5. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014; 11: 506-514 [PMID: 24912386 DOI: 10.1038/nrgastro.2014.66]
6. Malaguarnera G, Leggio F, Vacante M, Motta M, Giordano M, Bondi A, Basile F, Mastrojeni S, Mistretta A, Malaguarnera M, Toscano MA, Salmeri M. Probiotics in the gastrointestinal diseases of the elderly. J Nutr Health Aging 2012; 16: 402-410 [PMID: 22499466]
7. Girardin M, Seidman EG. Indications for the use of probiotics in gastrointestinal diseases. Dig Dis 2011; 29: 574-587 [PMID: 22179214]
8. Miller LE, Ouwehand AC. Probiotic supplementation decreases intestinal transit time: meta-analysis of randomized controlled trials. World J Gastroenterol 2013; 19: 4718-4725 [PMID: 23922468 DOI: 10.3748/wjg.v19.i29.4718]
9. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009; 151: W65-W94 [PMID: 19622512]
10. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12 [PMID: 8721797]
11. Cohen J. Statistical power analysis for the behavioral sciences. Hillside, NJ: Lawrence Erlbaum Associates, 1987
12. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Br Med J 2003; 327: 557-560 [PMID: 12958120 DOI: 10.1136/bmj.327.7414.557327/7414/557]
13. Egger M, Davey Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. Br Med J 1997; 315: 629-634 [PMID: 9310563]
14. Agrawal A, Houghton LA, Morris J, Reilly B, Guyonnet D, Goupil Feuillerat N, Schlumberger A, Jakob S, Whorwell PJ. Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173 010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2009; 29: 104-114 [PMID: 18801055]
15. Bartram HP, Scheppach W, Gerlach S, Ruckdeschel G, Kelber E, Kasper H. Does yogurt enriched with Bifidobacterium longum affect colonic microbiology and fecal metabolites in health subjects? Am J Clin Nutr 1994; 59: 428-432 [PMID: 8310997]
16. Bouvier M, Meance S, Bouley C, Berta J, Grimaud J. Effects of consumption of a milk fermented by the probiotic strain Bifidobacterium animalis DN-173 010 on colonic transit time in healthy humans. Biosci Microflora 2001; 20: 43-48 [DOI: 10.12938/bifidus1996.20.43]
17. Holma R, Hongisto SM, Saxelin M, Korpela R. Constipation is relieved more by rye bread than wheat bread or laxatives without increased adverse gastrointestinal effects. J Nutr 2010; 140: 534-541 [PMID: 20089780 DOI: 10.3945/jn.109.118570]
18. Hongisto SM, Paajanen L, Saxelin M, Korpela R. A combination of fibre-rich rye bread and yoghurt containing Lactobacillus GG improves bowel function in women with self-reported constipation. Eur J Clin Nutr 2006; 60: 319-324 [PMID: 16251881 DOI: 10.1038/sj.ejcn.1602317]
19. Malpeli A, González S, Vicentin D, Apás A, González HF. Randomised, double-blind and placebo-controlled study of the effect of a synbiotic dairy product on orocecal transit time in healthy adult women. Nutr Hosp 2012; 27: 1314-1319 [PMID: 23165580 DOI: 10.3305/nh.2012.27.4.5770]
20. Marteau P, Cuillerier E, Meance S, Gerhardt MF, Myara A, Bouvier M, Bouley C, Tondu F, Bommelaer G, Grimaud JC. Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study. Aliment Pharmacol Ther 2002; 16: 587-593 [PMID: 11876714 DOI: 10.1046/j.1365-2036.2002.01188.x]
21. Rosenfeldt V, Paerregaard A, Nexmann Larsen C, Moller PL, Tvede M, Sandstrom B, Jakobsen M, Michaelsen KF. Faecal recovery, mucosal adhesion, gastrointestinal effects and tolerance of mixed cultures of potential prebiotic lactobacilli. Microbial Ecology in Health and Disease 2003; 15: 2-9 [DOI: 10.1080/089106003100155 47]
22. Sairanen U, Piirainen L, Gråsten S, Tompuri T, Mättö J, Saarela M, Korpela R. The effect of probiotic fermented milk and inulin on the functions and microecology of the intestine. J Dairy Res 2007; 74: 367-373 [PMID: 17692137]
23. Waller PA, Gopal PK, Leyer GJ, Ouwehand AC, Reifer C, Stewart ME, Miller LE. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scand J Gastroenterol 2011; 46: 1057-1064 [PMID: 21663486 DOI: 10.3109/00365521.2011.584895]
24. Krammer HJ, Seggem HV, Schaumburg J, Neumer F. Effect of Lactobacillus casei Shirota on colonic transit time in patients with chronic constipation. Coloproctology 2011; 33: 109-113 [DOI: 10.1007/s00053-011-0177-0]
25. Bazzocchi G, Giovannini T, Giussani C, Brigidi P, Turroni S. Effect of a new synbiotic supplement on symptoms, stool consistency, intestinal transit time and gut microbiota in patients with severe functional constipation: a pilot randomized double-blind, controlled trial. Tech Coloproctol 2014; 18: 945-953 [PMID: 25091346 DOI: 10.1007/s10151-014-1201-5]
26. Magro DO, de Oliveira LM, Bernasconi I, Ruela Mde S, Credidio L, Barcelos IK, Leal RF, Ayrizono Mde L, Fagundes JJ, Teixeira Lde B, Ouwehand AC, Coy CS. Effect of yogurt containing polydextrose, Lactobacillus acidophilus NCFM and Bifidobacterium lactis HN019: a randomized, double-blind, controlled study in chronic constipation. Nutr J 2014; 13: 75 [PMID: 25056655 DOI: 10.1186/1475-2891-13-75]
27. Merenstein DJ, D'Amico F, Palese C, Hahn A, Sparenborg J, Tan T, Scott H, Polzin K, Kolberg L, Roberts R. Short-term, daily intake of yogurt containing Bifidobacterium animalis ssp. lactis Bf-6 (LMG 24384) does not affect colonic transit time in women. Br J Nutr 2014; 111: 279-286 [PMID: 24103188 DOI: 10.1017/S0007114513002237]
28. Tulk HM, Blonski DC, Murch LA, Duncan AM, Wright AJ. Daily consumption of a synbiotic yogurt decreases energy intake but does not improve gastrointestinal transit time: a double-blind, randomized, crossover study in healthy adults. Nutr J 2013; 12: 87 [PMID: 23787118 DOI: 10.1186/1475-2891-12-87]
29. Guinane CM, Cotter PD. Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therap Adv Gastroenterol 2013; 6: 295-308 [PMID: 23814609 DOI: 10.1177/1756283X13482996]
30. Hemarajata P, Versalovic J. Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therap Adv Gastroenterol 2013; 6: 39-51 [PMID: 23320049 DOI: 10.1177/1756283X12459294]
31. Sleator RD. Designer probiotics: Development and applications in gastrointestinal health. World J Gastrointest Pathophysiol 2015; 6: 73-78 [PMID: 26301121 DOI: 10.4291/wjgp.v6.i3.73]
32. Pandey V, Berwal V, Solanki N, Malik NS. Probiotics: Healthy bugs and nourishing elements of diet. J Int Soc Prev Community Dent 2015; 5: 81-87 [PMID: 25992331 DOI: 10.4103/2231-0762.155726]
33. Freeman PR. The performance of the two-stage analysis of twotreatment, two-period crossover trials. Stat Med 1989; 8: 1421-1432 [PMID: 2616932]
34. Didari T, Solki S, Mozaffari S, Nikfar S, Abdollahi M. A systematic review of the safety of probiotics. Expert Opin Drug Saf 2014; 13: 227-239 [PMID: 24405164 DOI: 10.1517/14740338.2014.872627]